Anti-Human Beta-Site APP Cleaving Enzyme 2 (CT) (BACE2)

Anti-Human Beta-Site APP Cleaving Enzyme 2 (CT) (BACE2)

Product No.: B363

[product_table name="All Top" skus="B363"]

- -
- -
Target
BACE2
Product Type
Polyclonal Antibody
Alternate Names
Beta-Site Amyloid Precursor Protein Cleaving Enzyme 2, Asp1, DRAP
Applications
IHC FFPE
,
WB

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Host Species
Rabbit
Immunogen
PN:B366
Product Concentration
0.5 mg/ml
Formulation
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Storage and Handling
This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Specificity
Rabbit Anti-Human Beta-Site APP Cleaving Enzyme 2 (BACE2) recognizes an epitope near the C-terminus of human, mouse and rat BACE2. This polyclonal antibody was purified using affinity chromatography.
Background
Accumulation of the amyloid-β (αβ) plaque in the cerebral cortex is a critical event in the pathogenesis of Alzheimer’s disease. αβ peptide is generated by proteolytic cleavage of the β-amyloid protein precursor (APP) at β- and γ-sites by proteases. The long-sought β-secretase was recently identified by several groups independently and designated β-site APP cleaving enzyme (BACE) and aspartyl protease 2 (Asp2).1-4 A BACE homolog was recently cloned and designated BACE2, Asp1, DRAP (for Down region aspartic protease), and memapsin 1.4-9 BACE2 also cleaves APP at β-site and at a different site within αβ.8 BACE2 locates on chromosome 21q22.3, the so-called ‘Down critical region’, suggesting that BACE2 and αβ may also contribute to the pathogenesis of Down syndrome.6,7

Antigen Details

PubMed
NCBI Gene Bank ID

References & Citations

1. Vassar R, et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999; 286:735-41. 2. Hussain I, et al. Identification of a novel aspartic protease (Asp2) as beta-secretase. Mol. Cell. Neurosci. 1999; 14:419-27. 3. Sinha S, et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 1999; 402:537-40. 4. Yan R, et al. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 1999; 402:533-7. 5. Lin X, et al. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc. Natl. Acad. Sci. USA 2000 15; 97:1456-60. 6. Acquati F, et al. The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region. FEBS Lett. 2000; 468:59-64. 7. Solans A, et al. A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer's amyloid precursor protein betasecretase. Cytogenet Cell Genet. 2000; 89:177-84. 8. Farzan M, et al. BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc. Natl. Acad. Sci. USA 2000; 97:9712-7. 9. Bennett BD, et al. Expression analysis of BACE2 in brain and peripheral tissues. J. Biol. Chem. 2000; 275:20647-51. (06-01D)
IHC FFPE
General Western Blot Protocol
Products are for research use only. Not for use in diagnostic or therapeutic procedures.